Qiming Venture Leads $17M Series A Round In Chinese Biotech Firm CureGenetics
August 7, 2018 — 11:03 CST
This Data Is Locked!
This area is available only to Subscribers.
Suzhou city, Jiangsu Province-based biotech firm CureGenetics Co., Ltd has raised a US$17 million series A round led by Qiming Venture Partners. CTS Capital and... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals